Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BOC cell adhesion associated, oncogene regulated (BOC) is a transmembrane cell-surface receptor that belongs to the immunoglobulin/fibronectin type III repeat family[4][5]. BOC acts as a coreceptor for Hedgehog (HH) ligands and is involved in the modulation of Hedgehog signaling, a pathway critical for embryonic development, neural patterning, myogenic differentiation, and craniofacial development[2][4]. Expressed highly in developing and some adult tissues—including articular cartilage and neuronal populations—BOC mediates cell-cell interactions and forms complexes with the related receptor CDON, as well as participating synergistically with other proteins like GAS1. Dysregulation or genetic loss of BOC function can result in developmental abnormalities including craniofacial defects and disordered neural patterning. While a promising candidate for study in cancer and developmental biology, BOC is not currently a direct therapeutic target of any drug, and no established pharmacological modulators are in clinical use[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BOC cell adhesion associated, oncogene regulated (BOC).